Informed-money record
SPRO · Spero Therapeutics, Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
11
Named actors
3
Disclosed $ (bull / bear)
$0 / $568K
Recent disclosures
11 of 11 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-05-04 | See Remarks Rajavelu Esther | sold | $63K | SEC ↗ |
| 2026-02-06 | Chief Operating Officer Keutzer Timothy | sold | $44K | SEC ↗ |
| 2026-02-06 | See Remarks Rajavelu Esther | sold | $88K | SEC ↗ |
| 2026-02-06 | See Remarks Rajavelu Esther | sold | $120K | SEC ↗ |
| 2026-02-04 | Chief Operating Officer Keutzer Timothy | sold | $8K | SEC ↗ |
| 2026-02-03 | Chief Operating Officer Keutzer Timothy | sold | $52K | SEC ↗ |
| 2026-02-02 | See Remarks Rajavelu Esther | sold | $41K | SEC ↗ |
| 2026-02-02 | Chief Operating Officer Keutzer Timothy | sold | $42K | SEC ↗ |
| 2025-11-07 | See Remarks Rajavelu Esther | sold | $95K | SEC ↗ |
| 2025-08-28 | Chief Operating Officer Keutzer Timothy | sold | $3K | SEC ↗ |
| 2025-08-28 | Director Mahadevia Ankit | sold | $13K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals